Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART)
Clinical trial NCT02047227 · COMPLETED
Trial details
- NCT number
- NCT02047227
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-31
- Primary completion
- 2015-08-31
- Enrollment
- 939
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.